BioTechPlex is an emerging drug discovery, development and delivery company focusing on the treatment of diseases of the airways, including emphysema, asthma, COPD, and cystic fibrosis. BioTechPlex provides enabling products for the discovery and development of respiratory and cardiac drugs as well as the evaluation of respiratory, cardiac and autonomic function. BioTechPlex's technologies address unmet needs for cell-based and small animal-based assays for target screening, validation and safety pharmacology and patient monitoring and respiratory aerosol drug delivery.